Get started
Author

M. Jardin-Szucs

Observed names: Meryam Jardin, Meryam Jardin-Szucs, Méryam Jardin-Szucs
Observed institution: Hôpital Paris Saint-Joseph
ORCID: 0000-0001-7007-0029
Observed ORCID: 0000-0001-7007-0029
OpenAlex ID: A5058151121
High-Dose Dexamethasone and Oxygen Support Strategies in Intensive Care Unit Patients With Severe COVID-19 Acute Hypoxemic Respiratory Failure: The COVIDICUS Randomized Clinical Trial
2022 · Lila Bouadma, Armand Mekontso-Dessap, et al. · JAMA Internal Medicine · 138
PDF
Answering Hospital Caregivers’ Questions at Any Time: Proof-of-Concept Study of an Artificial Intelligence–Based Chatbot in a French Hospital
2022 · Thomas Daniel, Alix de Chevigny, et al. · JMIR Human Factors · 20
PDF
Risk evaluation of the use of complementary and alternative medicines in cancer
2020 · S. Renet, A. de Chevigny, et al. · Annales Pharmaceutiques Françaises · 20
Cetuximab-induced aseptic meningitis: case report and review of a rare adverse event
2016 · Christophe Maritaz, Carole Metz, et al. · BMC Cancer · 17
PDF
Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial
2023 · Sylvie Chevret, Lila Bouadma, et al. · Annals of Intensive Care · 4
PDF
IMPACTCHIMIO : élaboration et validation multicentrique d’un outil de recueil des interventions pharmaceutiques réalisées au sein des unités de reconstitution de chimiothérapies
2020 · A. de Chevigny, M. Jardin-Szucs, et al. · Annales Pharmaceutiques Françaises · 3
Carbon Footprint of Injectable Chemotherapy in France: A Two Phase Life Cycle Assessment from Single Center to Multicenter Practice
2026 · Sophie Renet, Olivia Gautier, et al. · SSRN Electronic Journal
Works count: 7
Citation count: 202
H-index: 4
I10-index: 4
Year
Topic
Type